| Name | Title | Contact Details |
|---|---|---|
Karen Gibson |
Chief Technology Officer | Profile |
Karen Gibson |
Senior Vice President of Information Technology and Chief Information Officer | Profile |
Fidelis Care is the New York State Catholic Health Plan, providing quality, affordable, New York State-sponsored health insurance coverage for people of all ages and at all stages of life. From its origin in 1993 as the Catholic Health Services Plan of Brooklyn and Queens, Inc., Fidelis Care has grown -- both in the scope of its mission and the services it provides. Today, through a Statewide network of more than 67,000 providers, we support more than one million children and adults, making Fidelis Care one of the largest government programs-based health insurance plans in New York State. Fidelis Care offers free or low-cost comprehensive health insurance, including Medicaid Managed Care, Medicare Advantage, Child Health Plus, and products available through NY State of Health: The Official Health Plan Marketplace. Additionally, Fidelis Care offers Managed Long Term Care products for adults who qualify for nursing home care, but are capable of staying safely in their own homes with the right care and support.
MERIAL Limited is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. MERIAL Limited is based in Duluth, GA. You can find more information on MERIAL Limited at www.merial.com
As the nation’s leading community oncology alliance, RainTree Oncology Services assists our member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices through. Creating a unique aggregated data compilation and analytic platform allowing RainTree members to develop and evaluate care pathways to improve patient care and outcomes while reducing costs to the health care system; and Developing commercial relationships accelerating innovative oncology treatments and payer arrangements while optimizing oncology patient care and advancing the science of oncology.
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
You will find comfort, security, and gracious services that exceed your expectations in our communities. A caring staff will provide thoughtful attention to your needs. Old friends will want to visit. New neighbors will welcome you. The amenities of shops, restaurants, entertainment, events and churches are readily accessible in town. Year after year, residents and staff award our communities the highest satisfaction ratings in an independent survey.